| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $25M | — | — | — | — |
| Op. Income | $2M | — | — | — | — |
| Gross Margin | 39.0% | — | — | — | — |
| Net Margin | 7.9% | — | — | — | — |
| EPS (Diluted) | $0.29 | — | — | — | — |
| Free Cash Flow | $2M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $25M |
| Cost of Revenue | $15M |
| GROSS PROFIT | $10M |
| R&D Expenses | $376.0K |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $7M |
| Operating Expenses | $7M |
| Cost & Expenses | $23M |
| OPERATING INCOME | $2M |
| Interest Income | $0 |
| Interest Expense | $6.0K |
| Other Income/Expenses | $532.0K |
| INCOME BEFORE TAX | $3M |
| Income Tax Expense | $762.0K |
| Net Income from Continuing Ops | $2M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2M |
| D&A | $1M |
| EBIT | $2M |
| EBITDA | $4M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $25M |
| Cost of Revenue | $15M |
| GROSS PROFIT | $10M |
| R&D Expenses | $376.0K |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $7M |
| Operating Expenses | $7M |
| Cost & Expenses | $23M |
| OPERATING INCOME | $2M |
| Interest Income | $0 |
| Interest Expense | $6.0K |
| Other Income/Expenses | $532.0K |
| INCOME BEFORE TAX | $3M |
| Income Tax Expense | $762.0K |
| Net Income from Continuing Ops | $2M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2M |
| D&A | $1M |
| EBIT | $2M |
| EBITDA | $4M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $2M |
| Depreciation & Amortization | $202.0K |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $245.0K |
| Other Non-Cash Items | $1M |
| Change in Working Capital | -$2M |
| OPERATING CASH FLOW | $2M |
| Capital Expenditure | -$747.0K |
| Acquisitions (Net) | $132.0K |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $15.0K |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$607.0K |
| Net Debt Issuance | -$81.0K |
| Common Stock Repurchased | -$926.0K |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$1M |
| NET CASH FROM FINANCING | -$2M |
| FREE CASH FLOW | $2M |
| Net Change in Cash | -$610.0K |
| Item | Amount |
|---|---|
| Cash & Equivalents | $54M |
| Short-Term Investments | $121.0K |
| Net Receivables | $79M |
| Inventory | $3M |
| Other Current Assets | $2M |
| TOTAL CURRENT ASSETS | $138M |
| PP&E (Net) | $55M |
| Goodwill | $4M |
| Intangible Assets | $3M |
| Long-Term Investments | $0 |
| Tax Assets | $6M |
| Other Non-Current Assets | $2M |
| TOTAL NON-CURRENT ASSETS | $70M |
| TOTAL ASSETS | $208M |
| Account Payables | $953.0K |
| Short-Term Debt | $49.0K |
| Deferred Revenue | $4M |
| Other Current Liabilities | $2M |
| TOTAL CURRENT LIABILITIES | $12M |
| Long-Term Debt | $7.0K |
| Deferred Revenue NC | $1M |
| Deferred Tax Liabilities | $371.0K |
| Other Non-Current Liabilities | $119.0K |
| TOTAL NON-CURRENT LIABILITIES | $37M |
| TOTAL LIABILITIES | $49M |
| Common Stock | $1.0K |
| Additional Paid-In Capital | $179M |
| Retained Earnings | -$9M |
| Treasury Stock | -$395.0K |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $170M |
| Minority Interest | -$11M |
| TOTAL EQUITY | $159M |
| TOTAL LIABILITIES & EQUITY | $208M |
| Total Debt | $39M |
| Net Debt | -$15M |
